- Home
- MBWM vs AXGN Comparison
MBWM vs AXGN Comparison
Compare MBWM & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBWM
- AXGN
- Stock Information
- Founded
- MBWM 1997
- AXGN N/A
- Country
- MBWM United States
- AXGN United States
- Employees
- MBWM N/A
- AXGN N/A
- Industry
- MBWM Major Banks
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MBWM Finance
- AXGN Health Care
- Exchange
- MBWM Nasdaq
- AXGN Nasdaq
- Market Cap
- MBWM 709.3M
- AXGN 584.7M
- IPO Year
- MBWM 1997
- AXGN N/A
- Fundamental
- Price
- MBWM $49.10
- AXGN $12.64
- Analyst Decision
- MBWM Buy
- AXGN Strong Buy
- Analyst Count
- MBWM 2
- AXGN 4
- Target Price
- MBWM $52.00
- AXGN $15.00
- AVG Volume (30 Days)
- MBWM 59.5K
- AXGN 444.1K
- Earning Date
- MBWM 10-15-2024
- AXGN 11-07-2024
- Dividend Yield
- MBWM 2.93%
- AXGN N/A
- EPS Growth
- MBWM N/A
- AXGN N/A
- EPS
- MBWM 4.96
- AXGN N/A
- Revenue
- MBWM $222,191,000.00
- AXGN $180,855,000.00
- Revenue This Year
- MBWM N/A
- AXGN $18.91
- Revenue Next Year
- MBWM $0.96
- AXGN $12.93
- P/E Ratio
- MBWM $9.90
- AXGN N/A
- Revenue Growth
- MBWM 2.06
- AXGN 18.79
- 52 Week Low
- MBWM $33.46
- AXGN $5.55
- 52 Week High
- MBWM $51.31
- AXGN $15.90
- Technical
- Relative Strength Index (RSI)
- MBWM 60.37
- AXGN 42.96
- Support Level
- MBWM $47.87
- AXGN $12.18
- Resistance Level
- MBWM $51.06
- AXGN $14.17
- Average True Range (ATR)
- MBWM 1.47
- AXGN 1.00
- MACD
- MBWM 0.43
- AXGN -0.19
- Stochastic Oscillator
- MBWM 75.20
- AXGN 25.74
About MBWM Mercantile Bank Corporation
Mercantile Bank Corp operates as a bank holding company. It provides a variety of commercial banking services to individuals, businesses, governmental units, and other institutions. It provides banking services offering deposit products including checking, savings, and term certificate accounts, and lending products including commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.